13867711000001109: Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Cabergoline\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)
\UK product\Trade family\Dostinex\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing cabergoline\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing cabergoline\Cabergoline\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing cabergoline\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing cabergoline\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing cabergoline\Cabergoline\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing cabergoline\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing cabergoline\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing cabergoline\Cabergoline\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing cabergoline\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

49803901000001115 Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

78118301000001110 Dostinex 500microgram tablets (DE Pharmaceuticals) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel Import - supplier (qualifier value)	false	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel import	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Is a	Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Has active ingredient	Cabergoline	false	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Is a	Dostinex	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Has specific active ingredient	Cabergoline	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd) 8 tablet	Is pack of	False	Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd) 8 tablet	Has AMP	True	Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
49803901000001115	Dostinex 500microgram tablets (Doncaster Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
78118301000001110	Dostinex 500microgram tablets (DE Pharmaceuticals)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module